US Panel to Scrutinize Eyetech, Pfizer Eye Drug
77653
A US advisory panel on Friday will review data on an experimental drug that is injected into the eye to stop vision loss in elderly patients at risk of going blind.
704130
A new panel of outside experts will advise the U.S. Food and Drug Administration on how to tell the public about the risks and benefits of medicines and medical devices, the agency said on Monday.
402091
Eyetech (EYET:Nasdaq - news - research) did not open for trading Friday because a Food and Drug Administration advisory committee is meeting to review the small New York-based biotech&#39;s experimental eye disease drug.
639313
Six physicians with financial ties to Johnson &amp; Johnson and other heart-device makers will be advising US regulators whether to restrict the use of some products because of potentially lethal side effects.
210977
NEW YORK (CBS.MW) -- Shares of biotechnology company Eyetech Pharmaceuticals fell in after-hours trading Friday after a key US Food and Drug Administration advisory panel withheld approval for Macugen, a new drug to treat failing eyesight in the elderly.
765930
U.S. regulators said on Friday they  would review a study showing a Merck and Schering-Plough  cholesterol drug worked no better than a generic in preventing  the build-up of arterial plaque.
211271
Aug. 20 (Bloomberg) -- Antidepressant drugmakers such as Pfizer Inc., GlaxoSmithKline Plc and Wyeth will have to disclose trial results suggesting a higher risk of suicide among children and teenagers taking the pills, US regulators said.
439931
Wyeth said on Tuesday that U.S. regulators will review on an accelerated basis its experimental drug temsirolimus as a first line treatment for advanced renal cell carcinoma.
233864
Eyetech Pharmaceuticals (EYET:Nasdaq - news - research) faces an important regulatory test Aug. 27 when a Food and Drug Administration advisory panel will review Macugen, the company&#39;s experimental drug intended
158083
The FDA is investigating Teva's generic version of Wellbutrin XL.
458921
Congress is looking into whether the Food and Drug Administration ignored safety concerns about the drug raised by its own reviewers and outside scientists.
265781
The chairman of a House committee asked two medical device companies and three drug makers for documents as part of an investigation.
529585
WASHINGTON - A federal scientific advisory panel meets tomorrow to consider whether to recommend that a skin patch to enhance women&#39;s desire for sex should be licensed as a new drug.
598332
The FDA will review its new cholesterol drug.
231875
The US Food and Drug Administration (news - web sites) on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck &amp; Co.
280625
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
339005
A U.S. advisory panel on Friday will review data on an experimental drug that is injected into the eye to stop vision loss in elderly patients at risk of going blind.